Sickle cell disease: Continuous arterial spin-labeling perfusion MR imaging in children

Radiology

Volumn 227, Issue 2, 2003, Pages 567-574

  Oguz, Kader K ^a,b   Golay, Xavier ^a,b   Pizzini, Francesca B ^a,b   Freer, Catherine A ^a   Winrow, Nevada ^a   Ichord, Rebecca ^c   Casella, James F ^a   Van Zijl, Peter C M ^a,b   Melhem, Elias R ^a,b,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cerebral blood vessels, flow dynamics; Cerebral blood vessels, MR; Magnetic resonance (MR), in infants and children; Magnetic resonance (MR), perfusion study; Sickle cell disease (SS, SC)

Indexed keywords

ANTERIOR CEREBRAL ARTERY; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTINUOUS ARTERIAL SPIN LABELING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEMATOCRIT; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHOOL CHILD; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; CEREBROVASCULAR CIRCULATION; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0037406939     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2272020903     Document Type: Article

References (46)

1. Pavlakis SG, Prohovnik I, Piomelli S, De Vivo DC. Neurologic complications of sickle cell disease. Adv Pediatr 1989; 36: 247-276.
2. Portnoy BA, Herion JC. Neurological manifestations in sickle cell disease. Ann Intern Med 1972; 76:643-652.
3. Hindmarsh PC, Brozovic M, Brook CG, Davies SC. Incidence of overt and covert neurological damage in children with sickle cell disease. Postgrad Med J 1987; 63:751-753.
4. Adams RJ, Nichols FT, McKie V, et al. Cerebral infarction in sickle cell anemia. Neurology 1988; 38:1012-1017.
5. Huttenlocher PR, Moohr JW, Johns L, Brown FD. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 1984; 73:615-621.
6. Malouf AJ Jr, Hamrick-Turner JE, Doherty MC, Dhillon GS, Iyer RV, Smith MG. Implementation of the STOP protocol for stroke prevention in sickle cell anemia by using duplex power Doppler imaging. Radiology 2001; 219:359-365.
7. Wang WC, Gallagher DM, Pegelow CH, et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol 2000; 22:335-339.
8. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-11.
9. Seibert JJ, Glasier CM, Kirby RS, et al. Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia: an 8-year study. Pediatr Radiol 1998; 28:138-142.
10. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42:699-704.
11. Verlhac S, Bernaudin F, Tortrat D, et al. Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: correlation with MRI, MRA and conventional angiography. Pediatr Radiol 1995; 25(suppl 1):S14-S19.
12. Siegel MJ, Luker GD, Glauser TA, DeBaun MR. Cerebral infarction in sickle cell disease: transcranial Doppler US versus neurologic examination. Radiology 1995; 197:191-194.
13. Seibert JJ, Miller SF, Kirby RS, et al. Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US - correlation with MR imaging and MR angiography. Radiology 1993; 189:457-466.
14. Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992; 23:1073-1077.
15. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326:605-610.
16. Adams RJ, Nichols FT III, Aaslid R, et al. Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol 1990; 12:277-282.
17. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 1988; 23:125-130.
18. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle cell disease: a report from the cooperative study of sickle cell disease. AJNR Am J Neuroradiol 1996; 17:965-972.
19. Pegelow CH, Wang W, Granger S, et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol 2001; 58:2017-2021.
20. Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol 2000; 25:503-513.
21. DeBaun MR, Schatz J, Siegel MJ, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 1998; 50:1678-1682.
22. Schatz J, Brown RT, Pascual JM, Hsu L, DeBaun MR. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology 2001; 56:1109-1111.
23. Powars DR, Conti PS, Wong WY, et al. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood 1999; 93: 71-79.
24. Rodgers GP, Clark CM, Larson SM, et al. Brain glucose metabolism in neurologically normal patients with sickle cell disease. Arch Neurol 1988; 45:78-82.
25. Reed W, Jagust W, Al-Mateen M, Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 1999; 60:268-272.
26. Tzika AA, Massoth RJ, Ball WS, et al. Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*weighted MR images. Pediatr Radiol 1993; 187:449-458.
27. Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 2001; 49:477-485.
28. Herold S, Brozovic M, Gibbs J, et al. Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke 1986; 17:692-698.
29. Numaguchi Y, Haller JS, Humbert JR, et al. Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease. Neuroradiology 1990; 32:289-295.
30. Alsop D, Detre J. Reduced transit time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996; 16:1236-1249.
31. Alsop D, Detre J. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998; 208:410-416.
32. van Gelderen P, de Vleeschouwer MH, DesPres D, Pekar J, van Zijl PC, Moonen CT. Water diffusion and acute stroke. Magn Reson Med 1994; 31:154-163.
33. Woods RP, Mazziotta JC, Cherry SR. MRIPET registration with automated algorithm. J Comput Assist Tomogr 1993; 4:536-546.
34. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998; 50:1699-1708.
35. Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet 2001; 357: 1656-1659.
36. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 1989; 39:344-348.
37. Massik J, Tang YL, Hudak ML, et al. Effect of hematocrit on cerebral blood flow with induced polycythemia. J Appl Physiol 1987; 62:1090-1096.
38. Hudak ML, Tang YL, Massik J, et al. Baseline O2 extraction influences cerebral blood flow response to hematocrit. Am J Physiol 1988; 254(1 pt 2):H156-H162.
39. Hughes JG, Diggs LW, Gillespie CE. The involvement of the nervous system in sickle cell anemia. J Pediatr 1940; 17:166-184.
40. Schoning M, Hartig B. Age dependence of total cerebral blood flow volume from childhood to adulthood. J Cereb Blood Flow Metab 1996; 16:827-833.
41. Takahashi T, Shirane R, Sato S, Yoshimato T. Developmental changes of cerebral blood flow and oxygen metabolism in children. AJNR Am J Neuroradiol 1999; 20:917-922.
42. Steen RG, Langston JW, Ogg RJ, Xiong X, Ye Z, Wang WC. Diffuse T1 reduction in gray matter of sickle cell disease patients: evidence of selective vulnerability to damage? Magn Reson Imaging 1999; 17: 503-515.
43. Frackowiak RS, Lenzi GL, Jones T, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 150 and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980; 4:727-736.
44. Pantano P, Baron JC, Lebrun Grandie P, Duquesnoy N, Bousser MG, Comar D. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1984; 15:635-641.
45. Roberts DA, Rizi R, Lenkinski RE, Leigh JS Jr. Magnetic resonance imaging of the brain: blood partition coefficient for water: application to spin-tagging measurement of perfusion. J Magn Reson Imaging 1996; 6:363-366.
46. Ye FQ, Mattay VS, Jezzard P, Frank JA, Weinberger DR, McLaughlin AC. Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med 1997; 37:226-235.